A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 4,562,969 shares of BMY stock, worth $222 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
4,562,969
Previous 5,074,466 10.08%
Holding current value
$222 Million
Previous $275 Million 31.14%
% of portfolio
0.14%
Previous 0.19%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$40.25 - $52.99 $20.6 Million - $27.1 Million
-511,497 Reduced 10.08%
4,562,969 $190 Million
Q1 2024

Apr 19, 2024

SELL
$47.98 - $54.4 $24.9 Million - $28.3 Million
-519,626 Reduced 9.29%
5,074,466 $275 Million
Q4 2023

Jan 30, 2024

BUY
$48.48 - $57.85 $8.38 Million - $9.99 Million
172,769 Added 3.19%
5,594,092 $287 Million
Q3 2023

Oct 30, 2023

SELL
$57.89 - $64.73 $7.63 Million - $8.53 Million
-131,794 Reduced 2.37%
5,421,323 $315 Million
Q2 2023

Jul 31, 2023

SELL
$63.71 - $70.74 $51.1 Million - $56.7 Million
-801,341 Reduced 12.61%
5,553,117 $355 Million
Q1 2023

Apr 27, 2023

SELL
$65.71 - $74.53 $39.1 Million - $44.4 Million
-595,671 Reduced 8.57%
6,354,458 $440 Million
Q4 2022

Jan 30, 2023

SELL
$68.48 - $81.09 $8.27 Million - $9.79 Million
-120,762 Reduced 1.71%
6,950,129 $500 Million
Q3 2022

Oct 21, 2022

SELL
$0.13 - $76.84 $7,902 - $4.67 Million
-60,792 Reduced 0.85%
7,070,891 $503 Million
Q2 2022

Jul 26, 2022

SELL
$72.62 - $79.98 $19.2 Million - $21.2 Million
-265,078 Reduced 3.58%
7,131,683 $549 Million
Q1 2022

Apr 27, 2022

BUY
$61.48 - $73.72 $5.42 Million - $6.5 Million
88,154 Added 1.21%
7,396,761 $540 Million
Q4 2021

Feb 02, 2022

SELL
$53.63 - $62.52 $7.88 Million - $9.18 Million
-146,895 Reduced 1.97%
7,308,607 $456 Million
Q3 2021

Oct 25, 2021

SELL
$59.17 - $69.31 $35.2 Million - $41.3 Million
-595,693 Reduced 7.4%
7,455,502 $441 Million
Q2 2021

Aug 02, 2021

SELL
$61.91 - $67.42 $44.3 Million - $48.2 Million
-714,889 Reduced 8.16%
8,051,195 $538 Million
Q1 2021

Apr 30, 2021

BUY
$59.34 - $66.74 $8.88 Million - $9.99 Million
149,676 Added 1.74%
8,766,084 $553 Million
Q4 2020

Feb 05, 2021

SELL
$57.74 - $65.43 $62.9 Million - $71.2 Million
-1,088,718 Reduced 11.22%
8,616,408 $534 Million
Q3 2020

Oct 30, 2020

SELL
$57.43 - $63.64 $59.7 Million - $66.2 Million
-1,039,853 Reduced 9.68%
9,705,126 $585 Million
Q2 2020

Jul 27, 2020

SELL
$54.82 - $64.09 $57.3 Million - $67 Million
-1,045,934 Reduced 8.87%
10,744,979 $627 Million
Q1 2020

Apr 27, 2020

BUY
$46.4 - $67.43 $58.6 Million - $85.2 Million
1,263,572 Added 12.0%
11,790,913 $652 Million
Q4 2019

Jan 31, 2020

BUY
$49.21 - $64.19 $155 Million - $202 Million
3,140,646 Added 42.52%
10,527,341 $671 Million
Q3 2019

Oct 31, 2019

BUY
$42.77 - $50.71 $5.77 Million - $6.84 Million
134,804 Added 1.86%
7,386,695 $375 Million
Q2 2019

Jul 29, 2019

BUY
$44.62 - $49.34 $3.49 Million - $3.86 Million
78,260 Added 1.09%
7,251,891 $329 Million
Q1 2019

May 08, 2019

BUY
$45.12 - $53.8 $21.2 Million - $25.3 Million
469,453 Added 7.0%
7,173,631 $342 Million
Q4 2018

Feb 06, 2019

BUY
$48.76 - $63.23 $68 Million - $88.2 Million
1,394,335 Added 26.26%
6,704,178 $342 Million
Q3 2018

Nov 07, 2018

BUY
$55.19 - $62.25 $9.91 Million - $11.2 Million
179,607 Added 3.5%
5,309,843 $330 Million
Q2 2018

Aug 01, 2018

BUY
$50.53 - $62.98 $16.2 Million - $20.2 Million
320,015 Added 6.65%
5,130,236 $284 Million
Q1 2018

May 01, 2018

BUY
$59.92 - $68.98 $1.29 Million - $1.48 Million
21,521 Added 0.45%
4,810,221 $304 Million
Q4 2017

Feb 06, 2018

BUY
$59.94 - $65.35 $8.14 Million - $8.87 Million
135,762 Added 2.92%
4,788,700 $293 Million
Q3 2017

Nov 07, 2017

SELL
$55.23 - $63.74 $5.25 Million - $6.06 Million
-95,124 Reduced 2.0%
4,652,938 $297 Million
Q2 2017

Aug 07, 2017

BUY
N/A
4,748,062
4,748,062 $265 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $104B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Sumitomo Mitsui Trust Holdings, Inc. Portfolio

Follow Sumitomo Mitsui Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.